104 related articles for article (PubMed ID: 17316066)
1. Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays.
Henriksson E; Kjellén E; Wahlberg P; Wennerberg J; Kjellström JH
In Vitro Cell Dev Biol Anim; 2006; 42(10):320-3. PubMed ID: 17316066
[TBL] [Abstract][Full Text] [Related]
2. Morphometric and colorimetric analyses of human tumor cell line growth and drug sensitivity in soft agar culture.
Alley MC; Pacula-Cox CM; Hursey ML; Rubinstein LR; Boyd MR
Cancer Res; 1991 Feb; 51(4):1247-56. PubMed ID: 1705170
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
Heo DS; Park JG; Hata K; Day R; Herberman RB; Whiteside TL
Cancer Res; 1990 Jun; 50(12):3681-90. PubMed ID: 2340518
[TBL] [Abstract][Full Text] [Related]
4. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.
Perez RP; Godwin AK; Handel LM; Hamilton TC
Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
[TBL] [Abstract][Full Text] [Related]
6. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
van Tonder A; Joubert AM; Cromarty AD
BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
[TBL] [Abstract][Full Text] [Related]
7. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
Fricker SP; Buckley RG
Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
Carmichael J; DeGraff WG; Gazdar AF; Minna JD; Mitchell JB
Cancer Res; 1987 Feb; 47(4):936-42. PubMed ID: 3802100
[TBL] [Abstract][Full Text] [Related]
10. Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro.
McHale AP; McHale L
Cancer Lett; 1988 Aug; 41(3):315-21. PubMed ID: 3409210
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.
Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM
Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity and resistance of cultured human squamous carcinoma cells to cis-platinum and methotrexate.
Spiegel J; Carey TE; Shimoura S; Krause CJ
Otolaryngol Head Neck Surg; 1984 Oct; 92(5):524-31. PubMed ID: 6438583
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction of cisplatin and fosfomycin on squamous cell carcinoma cultures.
Olson JJ; Truelson JM; Street N
Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1253-7. PubMed ID: 7917210
[TBL] [Abstract][Full Text] [Related]
14. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatment.
Bauden M; Tassidis H; Ansari D
Toxicol Lett; 2015 Jul; 236(1):8-15. PubMed ID: 25917448
[TBL] [Abstract][Full Text] [Related]
16. Do Multiwell Plate High Throughput Assays Measure Loss of Cell Viability Following Exposure to Genotoxic Agents?
Mirzayans R; Andrais B; Murray D
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767065
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line.
Bopp SK; Lettieri T
BMC Pharmacol; 2008 May; 8():8. PubMed ID: 18513395
[TBL] [Abstract][Full Text] [Related]
18. Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line.
Sobrero AF; Bertino JR
Cancer Treat Rep; 1985 Mar; 69(3):279-83. PubMed ID: 4038918
[TBL] [Abstract][Full Text] [Related]
19. Does dexamethasone inhibit the antineoplastic effect of cisplatin and docetaxel in head and neck cancer cells?
Wagenblast J; Arnoldner C; Gstöttner W; Bisdas S; Mörtel S; May A; Hambek M
Anticancer Res; 2010 Jan; 30(1):123-7. PubMed ID: 20150626
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
